(SBS) Companhia de Saneamento - Ratings and Ratios
Water, Sewage, Treatment, Connections
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.8% |
| Value at Risk 5%th | 47.8% |
| Relative Tail Risk | -2.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.35 |
| Alpha | 47.55 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.465 |
| Beta | 0.433 |
| Beta Downside | 0.253 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.79% |
| Mean DD | 6.80% |
| Median DD | 5.59% |
Description: SBS Companhia de Saneamento October 30, 2025
Companhia de Saneamento Básico do Estado de São Paulo (SABESP, NYSE:SBS) is Brazil’s largest water-and-sewage utility, serving 9.5 million water connections and 8.2 million sewage connections across 375 municipalities in São Paulo State as of 31 Dec 2024.
Key recent metrics: • 2024 revenue of R$ 30.2 bn, up 3.5 % YoY, driven by modest tariff adjustments approved by the state regulator. • Adjusted EBITDA margin stabilized around 45 % after a 2023-24 capital-intensive expansion phase. • Net debt/EBITDA ratio sits at 2.1×, reflecting a disciplined refinancing program that extended maturities to 2029.
Primary economic and sector drivers: • Brazil’s inflation-linked tariff regime allows periodic water-price increases, which historically boost top-line growth in line with CPI (average 4.2 % YoY over the past five years). • Ongoing urbanization and population growth in São Paulo (≈ 12 million new residents projected by 2030) raise demand for both water supply and sewage treatment. • Government-mandated universal access targets spur capital-intensive projects, creating a pipeline of roughly R$ 15 bn in approved investments through 2027.
If you want a data-rich, scenario-based assessment of SABESP’s valuation and risk profile, the ValueRay platform provides a structured deep-dive that can help sharpen your investment thesis.
SBS Stock Overview
| Market Cap in USD | 18,314m |
| Sub-Industry | Water Utilities |
| IPO / Inception | 2002-05-10 |
| Return 12m vs S&P 500 | 35.7% |
| Analyst Rating | 4.50 of 5 |
SBS Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 2.61% |
| Yield on Cost 5y | 9.14% |
| Yield CAGR 5y | 2.76% |
| Payout Consistency | 74.6% |
| Payout Ratio | 42.4% |
SBS Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 35.67% |
| CAGR/Max DD Calmar Ratio | 1.50 |
| CAGR/Mean DD Pain Ratio | 5.25 |
| Current Volume | 956.4k |
| Average Volume | 1001.7k |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (8.03b TTM) > 0 and > 6% of Revenue (6% = 2.47b TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 5.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.80% (prev 2.80%; Δ -7.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 10.12b > Net Income 8.03b (YES >=105%, WARN >=100%) |
| Net Debt (29.96b) to EBITDA (13.97b) ratio: 2.14 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (683.1m) change vs 12m ago -0.08% (target <= -2.0% for YES) |
| Gross Margin 35.31% (prev 54.52%; Δ -19.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 47.89% (prev 46.72%; Δ 1.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.27 (EBITDA TTM 13.97b / Interest Expense TTM 1.48b) >= 6 (WARN >= 3) |
Altman Z'' 2.28
| (A) -0.02 = (Total Current Assets 12.56b - Total Current Liabilities 14.53b) / Total Assets 95.99b |
| (B) 0.19 = Retained Earnings (Balance) 18.25b / Total Assets 95.99b |
| (C) 0.14 = EBIT TTM 12.21b / Avg Total Assets 86.06b |
| (D) 0.80 = Book Value of Equity 42.71b / Total Liabilities 53.28b |
| Total Rating: 2.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.65
| 1. Piotroski 7.0pt |
| 2. FCF Yield 8.34% |
| 3. FCF Margin 24.46% |
| 4. Debt/Equity 0.82 |
| 5. Debt/Ebitda 2.14 |
| 6. ROIC - WACC (= 6.28)% |
| 7. RoE 20.28% |
| 8. Rev. Trend 67.69% |
| 9. EPS Trend -63.04% |
What is the price of SBS shares?
Over the past week, the price has changed by -5.34%, over one month by +3.84%, over three months by +19.53% and over the past year by +51.81%.
Is SBS a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.7 | 2.3% |
| Analysts Target Price | 25.7 | 2.3% |
| ValueRay Target Price | 35.1 | 39.5% |
SBS Fundamental Data Overview November 15, 2025
P/E Trailing = 13.3518
P/E Forward = 14.0056
P/S = 0.5285
P/B = 2.2408
P/EG = 2.55
Beta = 0.153
Revenue TTM = 41.21b BRL
EBIT TTM = 12.21b BRL
EBITDA TTM = 13.97b BRL
Long Term Debt = 21.86b BRL (from longTermDebt, last fiscal year)
Short Term Debt = 5.78b BRL (from shortTermDebt, last quarter)
Debt = 34.93b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.96b BRL (from netDebt column, last quarter)
Enterprise Value = 120.85b BRL (97.57b + Debt 34.93b - CCE 11.65b)
Interest Coverage Ratio = 8.27 (Ebit TTM 12.21b / Interest Expense TTM 1.48b)
FCF Yield = 8.34% (FCF TTM 10.08b / Enterprise Value 120.85b)
FCF Margin = 24.46% (FCF TTM 10.08b / Revenue TTM 41.21b)
Net Margin = 19.50% (Net Income TTM 8.03b / Revenue TTM 41.21b)
Gross Margin = 35.31% ((Revenue TTM 41.21b - Cost of Revenue TTM 26.66b) / Revenue TTM)
Gross Margin QoQ = 31.77% (prev 41.82%)
Tobins Q-Ratio = 1.26 (Enterprise Value 120.85b / Total Assets 95.99b)
Interest Expense / Debt = 1.95% (Interest Expense 679.5m / Debt 34.93b)
Taxrate = 33.40% (1.08b / 3.24b)
NOPAT = 8.13b (EBIT 12.21b * (1 - 33.40%))
Current Ratio = 0.86 (Total Current Assets 12.56b / Total Current Liabilities 14.53b)
Debt / Equity = 0.82 (Debt 34.93b / totalStockholderEquity, last quarter 42.71b)
Debt / EBITDA = 2.14 (Net Debt 29.96b / EBITDA 13.97b)
Debt / FCF = 2.97 (Net Debt 29.96b / FCF TTM 10.08b)
Total Stockholder Equity = 39.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.37% (Net Income 8.03b / Total Assets 95.99b)
RoE = 20.28% (Net Income TTM 8.03b / Total Stockholder Equity 39.62b)
RoCE = 19.86% (EBIT 12.21b / Capital Employed (Equity 39.62b + L.T.Debt 21.86b))
RoIC = 12.23% (NOPAT 8.13b / Invested Capital 66.51b)
WACC = 5.95% (E(97.57b)/V(132.49b) * Re(7.61%) + D(34.93b)/V(132.49b) * Rd(1.95%) * (1-Tc(0.33)))
Discount Rate = 7.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.03%
[DCF Debug] Terminal Value 80.04% ; FCFE base≈7.70b ; Y1≈8.75b ; Y5≈12.00b
Fair Price DCF = 304.1 (DCF Value 207.68b / Shares Outstanding 683.0m; 5y FCF grow 15.97% → 3.0% )
EPS Correlation: -63.04 | EPS CAGR: -29.95% | SUE: 0.15 | # QB: 0
Revenue Correlation: 67.69 | Revenue CAGR: 18.33% | SUE: 0.87 | # QB: 1
Additional Sources for SBS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle